Ashwin Lewis
Sleep and kidney health are closely linked. Poor sleep quality and duration have been associated with an increased risk of chronic kidney disease (CKD). Additionally, the use of sleeping pills has been linked to a higher risk of CKD and CKD progression to end-stage renal disease (ESRD). While sleeping pills are sometimes prescribed to dialysis patients with insomnia, studies have found that commonly used insomnia treatments, including cognitive behavioral therapy and antidepressant drugs, do not effectively improve sleep in this population. The complex relationship between sleeping pills and kidney disease remains an area of ongoing research, with the underlying mechanisms yet to be fully understood.
| Characteristics | Values |
|---|---|
| Prevalence of sleep disturbances among CKD patients | 80% |
| Sleeping pill use and CKD risk | Confirmed association |
| Sleeping pill use and CKD progression to ESRD | Increased risk |
| Sleeping pill use and increased mortality rate | Confirmed association |
| Commonly used insomnia treatments for dialysis patients | CBT-I, Trazodone |
| Effectiveness of CBT-I and Trazodone | No meaningful difference in symptoms |
| Risk of serious cardiac complications | Higher risk with Trazodone |
| Sleep duration and CKD risk | Less than 4 hours, 4 to 6 hours, and more than 8 hours associated with increased risk |
| Sleep quality and CKD risk | Difficulty falling asleep, using sleeping pills or sedatives associated with higher risk |
| Kidney function and sleep-wake cycle | Regulated by the sleep-wake cycle |
Explore related products
What You'll Learn
The link between sleeping pills and chronic kidney disease
Chronic kidney disease (CKD) is characterised by abnormalities in kidney function or structure, which can lead to health problems such as cardiovascular events, cardiovascular mortality, and all-cause mortality. The complex relationship between sleeping pills and CKD has not been extensively studied, although a correlation has been observed.
A retrospective cohort study found that sleeping pill use was associated with an increased risk of CKD and end-stage renal disease (ESRD). The study included 186,654 sleeping pill users and 373,308 non-users, and identified a number of specific sleeping pills that correlated with an increased risk of CKD, including brotizolam, chlordiazepoxide, clonazepam, diazepam, dormicum, estazolam, fludiazepam, flunitrazepam, nitrazepam, trazodone, zolpidem, and zopiclone.
Another study found that insomnia treatments such as cognitive behavioural therapy and the antidepressant drug trazodone did not help dialysis patients with insomnia. Interestingly, this study also found a higher risk of serious cardiac complications in patients prescribed trazodone.
Sleeping pills are well-known for their undesirable side effects, which are particularly risky for older adults. Benzodiazepines, for example, have been associated with adverse events such as falls, major fractures, and motor vehicle accidents. Furthermore, the use of benzodiazepines and zolpidem has been linked to a 15% increase in the mortality rate.
Dr. McMullan of the National Kidney Foundation has stated that kidney function is regulated by the sleep-wake cycle, and that nocturnal patterns can affect CKD. Dr. McMullan's research will focus on melatonin secretion and how it relates to kidney function. The study will also examine the impact of sleep duration on kidney function, blood pressure, and blood glucose levels.
Athletes and Sleeping Pills: A Common Practice?
You may want to see also
Explore related products
Prevalence of sleeping pill use in kidney patients
Sleep deprivation and sleep disorders have been linked to higher rates of diabetes and cardiovascular disease, and research has also found a correlation between sleep and kidney function. Studies have shown that people who sleep less tend to experience a faster decline in kidney function.
The correlation between sleeping pill use and chronic kidney disease (CKD) has not been extensively studied, and the relationship between the two remains poorly understood. However, some studies have found that the use of sleeping pills may be associated with an increased risk of CKD and its progression to end-stage renal disease (ESRD).
One nationwide population-based retrospective cohort study found that the incidence rate of CKD was 1.69 times higher in those who used sleeping pills compared to those who did not. The study also reported that the prevalence of sleep disturbances is estimated to be 80% among patients with CKD, indicating a potential correlation between sleeping pill use and CKD.
Another study reported that sleeping pill use was more frequently observed in patients with certain comorbidities such as hypertension, diabetes mellitus, stroke, liver cirrhosis, and hyperlipidemia. The study also found that the prevalence of sleeping pill use generally increased with age, and was higher in older adults, women, Caucasians, and current smokers.
The specific correlation between sleeping pill use and CKD progression requires further investigation, and more studies are needed to corroborate the findings.
Herbal Sleep Aids: Nature's Sleeping Pills
You may want to see also
Explore related products
Dialysis patients and sleeping pill prescriptions
Sleep and kidney health are closely linked. Kidney function is regulated by the sleep-wake cycle, which helps coordinate the kidneys' workload over 24 hours. Poor sleep quality and duration have been associated with an increased risk of chronic kidney disease (CKD).
Dialysis patients often suffer from insomnia, which can severely affect their quality of life. A recent study tested two common treatments for sleeplessness: cognitive behavioral therapy (CBT-I) and the antidepressant drug trazodone. Neither treatment made a meaningful difference in the symptoms of dialysis patients with insomnia.
Sleeping pill use has been associated with an increased risk of CKD and end-stage renal disease (ESRD). Benzodiazepines such as temazepam, lorazepam, alprazolam, and clonazepam have been prescribed in dialysis populations for the treatment of sleep disorders. However, the relationship between sleeping pill use and CKD remains poorly understood, and the mechanisms underlying this association are unclear.
Sleeping pills are known for their undesired side effects, including daytime sedation, confusion, cognitive deficits, dependency, and withdrawal. Benzodiazepines can cause adverse events such as falls, major fractures, and motor vehicle accidents, especially in older adults due to poor drug elimination. Additionally, the use of benzodiazepines and zolpidem has been linked to an increased mortality rate, particularly in patients undergoing dialysis.
While sleeping pills may be prescribed to dialysis patients, the potential risks and side effects should be carefully considered. Further research is needed to fully understand the complex relationship between sleeping pill use and CKD, as well as the impact of sleep on kidney health.
Sleep Bands: Wear, Rest, and Recharge
You may want to see also
Explore related products
Side effects of sleeping pills for kidney patients
While sleeping disorders are common among patients with chronic kidney disease (CKD), the relationship between sleeping pill use and CKD remains poorly understood. However, studies have found an association between sleeping pill use and an increased risk of CKD and end-stage renal disease (ESRD).
Sleeping pills have been linked to several side effects in kidney patients, including:
- Daytime sedation
- Confusion
- Cognitive deficits
- Dependency
- Withdrawal
- Rebound symptoms
- Ataxia
- Dysarthria
- Diplopia
- Vertigo
In addition, the use of benzodiazepines, a common class of drugs used as sleep aids, has been associated with adverse events such as falls, major fractures, and motor vehicle accidents, especially in elderly patients. Benzodiazepines can also cause an increase in mortality rates, with studies showing a 15% increase in patients undergoing dialysis.
Furthermore, certain benzodiazepines, such as those containing propylene glycol, may cause acute kidney injury, proximal tubule injury, hyperosmolarity, and sepsis-like syndrome. Renal drug clearance mechanisms may be compromised in CKD and ESRD, leading to drug side effects and cumulative effects on the kidneys.
While insomnia is a common issue for dialysis patients, standard treatments such as cognitive behavioral therapy (CBT-I) and antidepressant drugs like trazodone have been found to be ineffective in improving sleep quality in this population.
Stomach Sleepers: Embrace Body Pillows for Better Rest
You may want to see also
Explore related products
Alternative treatments for kidney patients with insomnia
Sleep disturbances are estimated to affect 80% of patients with chronic kidney disease (CKD). While sleeping pills are sometimes prescribed to treat insomnia in these patients, there is a well-documented association between their use and an increased risk of CKD and end-stage renal disease (ESRD).
A study published in the *Annals of Internal Medicine* tested two commonly used treatments for insomnia—cognitive behavioural therapy (CBT-I) and the antidepressant drug trazodone—on dialysis patients. Neither treatment was found to have a meaningful impact on symptoms.
However, this does not mean that there are no alternative treatments for kidney patients with insomnia. Here are some potential options:
- Acupressure and accupoint massage: Evidence from several RCTs suggests that acupressure may be a safe alternative therapy for insomnia in ESRD patients.
- Exercise: Physical exercise, particularly aerobic or resistance exercises, has been shown to have beneficial effects on slowing the decline of renal function and improving sleep quality in the general population. While more research is needed to confirm these effects in ESRD patients, this could be another safe alternative treatment for kidney patients with insomnia.
- Sleep hygiene evaluation: For patients with conventional insomnia, a sleep hygiene evaluation is recommended. This may include a referral for a full evaluation, including somnography, if sleep apnea is suspected.
- Addressing medication side effects: Insomnia in dialysis patients may be driven by the side effects or interactions of multiple medications. Adjustments to medication may help improve sleep quality.
Effective Over-the-Counter Sleep Aids and How They Work
You may want to see also
Frequently asked questions
There is a reported association between sleeping pill use and an increased risk of chronic kidney disease (CKD) and CKD progression to end-stage renal disease (ESRD). Therefore, it is not recommended for kidney patients to take sleeping pills.
Cognitive behavioural therapy (CBT) is one alternative treatment for insomnia that does not involve medication.
The relationship between sleeping pills and CKD is complex and not yet fully understood. Further research is needed to corroborate the findings of existing studies. However, it is known that persistent use of sleeping pills after a CKD diagnosis increases the risk of concurrent ESRD.
Sleeping pills are well known for their undesired side effects, including daytime sedation, confusion, cognitive deficits, dependency, withdrawal, rebound symptoms, ataxia, dysarthria, diplopia, and vertigo.
